Business
WHO testing three new drugs artesunate, imatinib and infliximab against COVID in clinical trial – 7NEWS.com.au
A trio of anti-inflammatory drugs are being tested for use in virus patients.
The World Health Organisation says a clinical trial in 52 countries will study three anti-inflammatory drugs as potential treatments for COVID-19 patients.
These therapies – artesunate, imatinib and infliximab – were selected by an independent expert panel…
Continue Reading
-
Noosa News17 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference
-
Business20 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business17 hours agoDicker Data rides the AI trend to double digit growth
-
Noosa News17 hours agoBob Katter threatens Channel 9 journalist for asking question on family heritage